Found: 15
Select item for more details and to access through your institution.
Arsenic Trioxide and Venetoclax Synergize against AML Progenitors by ROS Induction and Inhibition of Nrf2 Activation.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 12, p. 6568, doi. 10.3390/ijms23126568
- By:
- Publication type:
- Article
IL1RAP-specific T cell engager depletes acute myeloid leukemia stem cells.
- Published in:
- Journal of Hematology & Oncology, 2024, v. 17, n. 1, p. 1, doi. 10.1186/s13045-024-01586-x
- By:
- Publication type:
- Article
Treatment-induced arteriolar revascularization and miR-126 enhancement in bone marrow niche protect leukemic stem cells in AML.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01133-y
- By:
- Publication type:
- Article
Targeting miR-126 in inv(16) acute myeloid leukemia inhibits leukemia development and leukemia stem cell maintenance.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-26420-7
- By:
- Publication type:
- Article
A phase 1 trial of 8‐chloro‐adenosine in relapsed/refractory acute myeloid leukemia: An evaluation of safety and pharmacokinetics.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 5, p. 727, doi. 10.1002/cncr.35077
- By:
- Publication type:
- Article
Targeting the metabolic vulnerability of acute myeloid leukemia blasts with a combination of venetoclax and 8-chloro-adenosine.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01076-4
- By:
- Publication type:
- Article
Phosphorylation stabilized TET1 acts as an oncoprotein and therapeutic target in B cell acute lymphoblastic leukemia.
- Published in:
- Science Translational Medicine, 2023, v. 15, n. 689, p. 1, doi. 10.1126/scitranslmed.abq8513
- By:
- Publication type:
- Article
Synergy of Venetoclax and 8-Chloro-Adenosine in AML: The Interplay of rRNA Inhibition and Fatty Acid Metabolism.
- Published in:
- Cancers, 2022, v. 14, n. 6, p. 1446, doi. 10.3390/cancers14061446
- By:
- Publication type:
- Article
Requirement of GTP binding for TIF‐90‐regulated ribosomal RNA synthesis and oncogenic activities in human colon cancer cells.
- Published in:
- Journal of Cellular Physiology, 2020, v. 235, n. 10, p. 7567, doi. 10.1002/jcp.29661
- By:
- Publication type:
- Article
Ebp1 p48 promotes oncogenic activities in human colon cancer cells through regulation of TIF‐90‐mediated ribosomal RNA synthesis.
- Published in:
- Journal of Cellular Physiology, 2019, v. 234, n. 10, p. 17612, doi. 10.1002/jcp.28385
- By:
- Publication type:
- Article
8‐chloro‐adenosine activity in FLT3‐ITD acute myeloid leukemia.
- Published in:
- Journal of Cellular Physiology, 2019, v. 234, n. 9, p. 16295, doi. 10.1002/jcp.28294
- By:
- Publication type:
- Article
The Bcl‐2 inhibitor venetoclax inhibits Nrf2 antioxidant pathway activation induced by hypomethylating agents in AML.
- Published in:
- Journal of Cellular Physiology, 2019, v. 234, n. 8, p. 14040, doi. 10.1002/jcp.28091
- By:
- Publication type:
- Article
The role of ErbB3 binding protein 1 in cancer: Friend or foe?
- Published in:
- Journal of Cellular Physiology, 2018, v. 233, n. 12, p. 9110, doi. 10.1002/jcp.26951
- By:
- Publication type:
- Article
Regulation of Ribosomal Gene Expression in Cancer.
- Published in:
- Journal of Cellular Physiology, 2015, v. 230, n. 6, p. 1181, doi. 10.1002/jcp.24854
- By:
- Publication type:
- Article
Reversibility of Defective Hematopoiesis Caused by Telomere Shortening in Telomerase Knockout Mice.
- Published in:
- PLoS ONE, 2015, v. 10, n. 7, p. 1, doi. 10.1371/journal.pone.0131722
- By:
- Publication type:
- Article